Publication
Title
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms
Author
Abstract
Mucosal biofilm-related fungal infections are very common and the incidence of recurrent oral and vulvovaginal candidiasis is significant. As resistance against azoles (preferred treatment) is occurring, we aimed at identifying compounds that increase the activity of miconazole against Candida albicans biofilms. We screened 1600 compounds of a drug repositioning library in combination with a sub-inhibitory concentration of miconazole. Synergy between the best identified potentiators and miconazole was characterized by checkerboard analyses and fractional inhibitory concentration indices. Hexachlorophene, pyrvinium pamoate and artesunate act synergistically with miconazole in affecting C. albicans biofilms. Synergy was most pronounced for artesunate and structural homologues thereof. No synergistic effect could be observed between artesunate and fluconazole, caspofungin or amphotericin B. Our data reveal enhancement of the antibiofilm activity of miconazole by artesunate, pointing to potential combination therapy consisting of miconazole and artesunate to treat C. albicans biofilm-related infections.
Language
English
Source (journal)
Antimicrobial agents and chemotherapy. - Washington, D.C., 1972, currens
Publication
Washington, D.C. : American Society for Microbiology , 2015
ISSN
0066-4804
DOI
10.1128/AAC.04229-14
Volume/pages
59 :1 (2015) , p. 421-426
ISI
000348609500051
Pubmed ID
25367916
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Project info
The role of bacterial biofilms as a major cause of therapeutic failure in intensive care units (ICU): an in vitro and in vivo study of 'biofilm' virulence factors.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 28.11.2014
Last edited 28.01.2024
To cite this reference